Editas: Q1 Earnings Snapshot
By Ap News
Published - May 08, 2024, 07:30 AM ET
Last Updated - May 08, 2024, 07:30 AM EDT
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $62 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of 76 cents per share.
The results fell short of Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.
The genome editing company posted revenue of $1.1 million in the period, which also missed Street forecasts. Six analysts surveyed by Zacks expected $11.7 million.
